Puszkiel, Alicja http://orcid.org/0000-0003-2954-4418
Bianconi, Guillaume
Pasquiers, Blaise http://orcid.org/0009-0000-9459-082X
Balakirouchenane, David
Arrondeau, Jennifer
Boudou-Rouquette, Pascaline
Bretagne, Marie-Claire
Salem, Joe-Elie
Declèves, Xavier
Vidal, Michel
Kramkimel, Nora
Guegan, Sarah
Aractingi, Selim
Huillard, Olivier http://orcid.org/0000-0001-9764-0845
Alexandre, Jérôme http://orcid.org/0000-0001-5252-5800
Wislez, Marie
Goldwasser, François
Blanchet, Benoit
Article History
Received: 3 October 2023
Revised: 5 March 2024
Accepted: 12 March 2024
First Online: 26 March 2024
Competing interests
: AP received speaking fees from Bristol Myers Squibb, Eisai and Pierre Fabre Oncology. BP is employed by PhinC Development (Contract Research Organization). J-ES participated in advisory boards, consultancy or received grants from Bristol Myers Squibb, Novartis, AstraZeneca, CRC-Oncology, Servier, IPSEN, Eisai and BeiGene. SG participated in advisory board, consultancy or received grants from Janssen, Bristol Myers Squibb, Pierre Fabre and Sanofi. OH received honoraria from Sanofi, Bayer, MSD, Bristol Myers Squibb, Ipsen, Pfizer, Eisai, Janssen, AstraZeneca and Merck. JAl participated to advisory boards, consultancy or received grants from Astra Zeneca, GSK, MSD, Eisai, Novartis, Janssen. PB-R received travel fees from Pharmamar, Pfizer and grants from Ipsen. MW participated to advisory boards, consultancy or received grants from MSD, Bristol Myers Squibb, Novartis, AstraZeneca, Sanofi, Janssen and Pfizer. JAr participed in advisory board or speaking and received travel fees from Bristol Myers Squibb, Takeda, Pfizer and AstraZeneca. BB received consulting and speaking fees from Bristol Myers Squibb, Clovis Oncology, Janssen, Pierre Fabre, Pfizer and Promise. The remaining authors declare no competing interests.
: The study was approved by the Institutional Review Board for retrospective analysis of the data collected as part of routine clinical practice and was conducted according to the declaration of Helsinki. Patients provided written informed consent (Cochin University Hospital: CERTIM cohort, Pitié-Salpétrière Hospital: MASC cohort, NCT04637672).